Tumor-associated antigen 90K activates myelomonocytic cell line THP-1

被引:16
作者
Altindag, ZZ
Marth, C
WernerFelmayer, G
Natoli, C
Zeimet, AG
Wachter, H
Iacobelli, S
Fuchs, D
机构
[1] UNIV INNSBRUCK, INST MED CHEM & BIOCHEM, A-6020 INNSBRUCK, AUSTRIA
[2] UNIV INNSBRUCK, LUDWIG BOLTZMANN INST AIDS RES, A-6020 INNSBRUCK, AUSTRIA
[3] UNIV INNSBRUCK, DEPT OBSTET & GYNECOL, A-6020 INNSBRUCK, AUSTRIA
[4] UNIV G DANNUNZIO, CATTEDRA ONCOL MED, CHIETI, ITALY
关键词
90K; interferon-gamma; neopterin formation; tryptophan degradation; monocytes;
D O I
10.1016/0304-3835(96)04364-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
90K is a tumor-associated antigen. Using myelomonocytic cell line THP-1 we determined neopterin production and tryptophan degradation after exposure of cells to 90K in the presence and the absence of interferon-gamma. Interferon-gamma is a well known stimulus for THP-1 cells inducing e.g. neopterin production and tryptophan degradation. Treatment of cells with 50 mu g/ml 90K induced significant neopterin formation, and the exposure of cells to 90K in addition to 100 U/ml interferon-gamma amplified neopterin production compared to the sole effect of interferon-gamma. In parallel, a significant degradation of tryptophan was observed in culture supematants leading to the formation of kynurenine. When the cells were treated with the combination of 90K and interferon-gamma the degradation of tryptophan was further enhanced. The data demonstrate that tumor-associated antigen 90K interferes with immunocompetent target cells and is able to induce a biochemical response in monocytic cells.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 26 条
  • [1] REMOVAL OF ENDOTOXIN FROM PROTEIN SOLUTIONS BY PHASE-SEPARATION USING TRITON X-114
    AIDA, Y
    PABST, MJ
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1990, 132 (02) : 191 - 195
  • [2] BERCHTOLD C, 1995, CANC LETT, V94, P227
  • [3] SELECTIVE INDUCTION OF MONONUCLEAR PHAGOCYTES TO PRODUCE NEOPTERIN BY INTERFERONS
    BITTERLICH, G
    SZABO, G
    WERNER, ER
    LARCHER, C
    FUCHS, D
    HAUSEN, A
    REIBNEGGER, G
    SCHULZ, TF
    TROPPMAIR, J
    WACHTER, H
    DIERICH, MP
    [J]. IMMUNOBIOLOGY, 1988, 176 (03) : 228 - 235
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] A 90-KDA PROTEIN SERUM MARKER FOR THE PREDICTION OF PROGRESSION TO AIDS IN A COHORT OF HIV-1+ HOMOSEXUAL MEN
    BRIGGS, NC
    NATOLI, C
    TINARI, N
    DEGIDIO, M
    GOEDERT, JJ
    IACOBELLI, S
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (09) : 811 - 816
  • [6] WEIGHT-LOSS IN PATIENTS WITH HEMATOLOGICAL NEOPLASIAS IS ASSOCIATED WITH IMMUNE-SYSTEM STIMULATION
    DENZ, H
    ORTH, B
    WEISS, G
    HERRMANN, R
    HUBER, P
    WACHTER, H
    FUCHS, D
    [J]. CLINICAL INVESTIGATOR, 1993, 71 (01): : 37 - 41
  • [7] FUCHS D, 1990, J ACQ IMMUN DEF SYND, V3, P873
  • [8] GASSE T, 1994, EUR J CLIN CHEM CLIN, V32, P685
  • [9] IMMUNE-RESPONSE ASSOCIATED PRODUCTION OF NEOPTERIN - RELEASE FROM MACROPHAGES PRIMARILY UNDER CONTROL OF INTERFERON-GAMMA
    HUBER, C
    BATCHELOR, JR
    FUCHS, D
    HAUSEN, A
    LANG, A
    NIEDERWIESER, D
    REIBNEGGER, G
    SWETLY, P
    TROPPMAIR, J
    WACHTER, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) : 310 - 316
  • [10] PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN BREAST-CANCER
    IACOBELLI, S
    SISMONDI, P
    GIAI, M
    DEGIDIO, M
    TINARI, N
    AMATETTI, C
    DISTEFANO, P
    NATOLI, C
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (01) : 172 - 176